Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Molecular Sciences|March 29, 2023
Structure and Dynamics of Three <i>Escherichia coli</i> NfsB Nitro-Reductase Mutants Selected for Enhanced Activity with the Cancer Prodrug CB1954Martin A Day, Andrew J Christofferson, J L Ross Anderson, et al.The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Adenovirus-mediated expression of dominant negative fibroblast growth factor (FGF) receptor 1 in thyroid cells blocks FGF effects and reduces goitrogenesis in miceEmma L Davies, James D Ramsden, Helen Cocks, et al.Cancer Immunology Research|February 26, 2015
Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal CarcinomaYong Zheng, Greg Parsonage, Xiaodong Zhuang, et al.Bioorganic & Medicinal Chemistry Letters|May 31, 2011
Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugsLongqin Hu, Xinghua Wu, Jiye Han, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]Prashant Patel, J Graham Young, Vivien Mautner, et al.Clinical and Experimental Pharmacology & Physiology|November 30, 2004
Nitroreductase: a prodrug-activating enzyme for cancer gene therapyPeter F Searle, Ming-Jen Chen, Longqin Hu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancerDaniel H Palmer, Vivien Mautner, Darius Mirza, et al.Pageof 3